Vienna, March 20, 2015 – The Supervisory Board of Lenzing AG appointed Stefan Doboczky as the new Chairman of the Management Board (CEO) of Lenzing AG. Mr. Doboczky will assume his new function on June 1st 2015. He takes over from Peter Untersperger, who will step down from his function as CEO per 31 May 2015 at his own request prematurely.
Mr. Doboczky, Austrian, brings to Lenzing a broad international management experience and extensive expertise in Asia. Since 1998 he has worked in various management positions for the Dutch Life Science & Material Science group Royal DSM in Europe and Asia. In his current role as Member of the Managing Board he has been responsible for the successful strategic repositioning of the global pharmaceutical businesses, for Corporate Operations & Responsible Care, as well as for the corporation’s growth agenda in the Asian markets. Mr. Doboczky holds a PhD in chemistry from the TU Wien and a MBA from Swiss Business School IMD .
Hanno Bästlein, Chairman of the Nomination Committee of the Supervisory Board of Lenzing AG, said about the appointment of the new CEO: “With his international industrial expertise, his close to ten years of management experience in Asia and his strong technical background, Stefan Doboczky will strengthen the Management Board team and is ideally suited to lead the Lenzing Group towards further growth.”